Geneos Wealth Management’s Essent Group ESNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19
Closed -$1.15K 2711
2025
Q2
$1.15K Sell
19
-38
-67% -$2.19K ﹤0.01% 2942
2025
Q1
$3.29K Buy
57
+38
+200% +$2.15K ﹤0.01% 2862
2024
Q4
$1.03K Hold
19
﹤0.01% 2762
2024
Q3
$1.22K Buy
+19
New +$1.16K ﹤0.01% 2400
2020
Q4
Sell
-400
Closed -$14K 2920
2020
Q3
$14K Hold
400
﹤0.01% 1820
2020
Q2
$13K Buy
+400
New +$12.3K ﹤0.01% 1799
2018
Q2
Sell
-300
Closed -$12K 2278
2018
Q1
$12K Buy
300
+100
+50% +$4.54K ﹤0.01% 1573
2017
Q4
$8K Hold
200
﹤0.01% 1698
2017
Q3
$8K Hold
200
﹤0.01% 1635
2017
Q2
$7K Hold
200
﹤0.01% 1633
2017
Q1
$7K Hold
200
﹤0.01% 1592
2016
Q4
$6K Buy
+200
New +$5.89K ﹤0.01% 1569

Other funds holding ESNT

Geneos Wealth Management's ESNT Position: Q3 2025 in Review

Geneos Wealth Management sold out of Essent Group (ESNT) in Q3 2025, closing a stake of 19 shares — an estimated $1.15K sold.

Geneos Wealth Management first reported a position in ESNT in Q4 2016 and held it in 12 quarters. The position peaked at $14K in Q3 2020. 350 funds tracked by Wall St. Rank hold ESNT as of Q3 2025.

  • Geneos Wealth Management reported no remaining Essent Group position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 19 Essent Group shares in Q3 2025, an estimated $1.15K.
  • Geneos Wealth Management first reported a position in Essent Group in Q4 2016 and held it in 12 quarters.
  • Geneos Wealth Management's Essent Group position peaked at $14K in Q3 2020.
  • 350 funds tracked by Wall St. Rank held Essent Group as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.